Dr. Rupali Roy Bhave
Claim this profileWake Forest Baptist Health, Section on Hematology & Oncology
Studies Acute Myeloid Leukemia
Studies Preleukemia
2 reported clinical trials
4 drugs studied
Area of expertise
1Acute Myeloid Leukemia
FLT3 positive
D835 positive
2Preleukemia
RARA positive
Affiliated Hospitals
Clinical Trials Rupali Roy Bhave is currently running
Crenolanib vs Midostaurin
for Acute Myeloid Leukemia
A phase III randomized multi-center study designed to compare the efficacy of crenolanib with that of midostaurin when administered following induction chemotherapy, consolidation chemotherapy and bone marrow transplantation in newly diagnosed AML subjects with FLT3 mutation. About 510 subjects will be randomized in a 1:1 ratio to receive either crenolanib in addition to standard first line treatment of AML (chemotherapy and if eligible, transplantation) (arm A) or midostaurin and standard treatment (arm B). Potentially eligible subjects will be registered and tested for the presence of FLT3 mutation. Once the FLT3 mutation status is confirmed and additional eligibility is established, subject will be randomized and enter into the treatment phase.
Recruiting3 awards Phase 3
Tamibarotene + Azacitidine
for Myelodysplastic Syndrome
This study compares the efficacy of Tamibarotene in combination with azacitidine to azacitidine in combination with placebo in participants who are Retinoic Acid Receptor Alpha (RARA) positive, and newly diagnosed with higher-risk myelodysplastic syndrome (HR-MDS), and who have not received treatment for this diagnosis. The primary goal of the study is to compare the complete remission rate between the two treatment arms.
Recruiting1 award Phase 34 criteria
More about Rupali Roy Bhave
Clinical Trial Related6 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Rupali Roy Bhave has experience with
- Crenolanib
- Midostaurin
- Azacitidine
- Tamibarotene
Breakdown of trials Rupali Roy Bhave has run
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rupali Roy Bhave specialize in?
Rupali Roy Bhave focuses on Acute Myeloid Leukemia and Preleukemia. In particular, much of their work with Acute Myeloid Leukemia has involved FLT3 positive patients, or patients who are D835 positive.
Is Rupali Roy Bhave currently recruiting for clinical trials?
Yes, Rupali Roy Bhave is currently recruiting for 2 clinical trials in Winston-Salem North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Rupali Roy Bhave has studied deeply?
Yes, Rupali Roy Bhave has studied treatments such as Crenolanib, Midostaurin, Azacitidine.
What is the best way to schedule an appointment with Rupali Roy Bhave?
Apply for one of the trials that Rupali Roy Bhave is conducting.
What is the office address of Rupali Roy Bhave?
The office of Rupali Roy Bhave is located at: Wake Forest Baptist Health, Section on Hematology & Oncology, Winston-Salem, North Carolina 27157 United States. This is the address for their practice at the Wake Forest Baptist Health, Section on Hematology & Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.